Efferocytosis and Atherosclerosis: Regulation of Phagocyte Function by MicroRNAs
- PMID: 31383556
- DOI: 10.1016/j.tem.2019.07.006
Efferocytosis and Atherosclerosis: Regulation of Phagocyte Function by MicroRNAs
Abstract
There is evidence of the critical role of efferocytosis, the clearance of apoptotic cells (ACs) by phagocytes, in vascular cell homeostasis and protection against atherosclerosis. Specific microRNAs (miRs) can regulate atherogenesis by controlling the accumulation of professional phagocytes (e.g., macrophages) and nonprofessional phagocytes (i.e., neighboring tissue cells with the ability to acquire a macrophage-like phenotype) within the arterial wall, the differentiation of phagocytes into foam cells, the efferocytosis of apoptotic foam cells by phagocytes, and the phagocyte-mediated inflammatory response. A better understanding of the mechanisms involved in miR-regulated phagocyte function might lead to novel therapeutic antiatherosclerotic strategies. In this review, we try to shed light on the relationship between miRs and cellular players in the process of efferocytosis in the context of atherosclerotic plaque and their potential as molecular targets for novel antiatherosclerotic therapies.
Keywords: apoptosis; atherosclerosis; efferocytosis; microRNA; ‘eat-me’ signals; ‘find-me’ signals.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis.Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1058-1067. doi: 10.1161/ATVBAHA.116.308916. Epub 2017 Apr 20. Arterioscler Thromb Vasc Biol. 2017. PMID: 28428217 Free PMC article.
-
The Impaired Mechanism and Facilitated Therapies of Efferocytosis in Atherosclerosis.J Cardiovasc Pharmacol. 2022 Sep 1;80(3):407-416. doi: 10.1097/FJC.0000000000001311. J Cardiovasc Pharmacol. 2022. PMID: 35853202 Review.
-
Regulation of efferocytosis by caspase-dependent apoptotic cell death in atherosclerosis.Int J Biochem Cell Biol. 2020 Mar;120:105684. doi: 10.1016/j.biocel.2020.105684. Epub 2020 Jan 3. Int J Biochem Cell Biol. 2020. PMID: 31911118 Review.
-
Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis.Front Endocrinol (Lausanne). 2021 Feb 1;11:585285. doi: 10.3389/fendo.2020.585285. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33597922 Free PMC article. Review.
-
Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.Pharmacol Ther. 2018 Aug;188:12-25. doi: 10.1016/j.pharmthera.2018.02.003. Epub 2018 Feb 11. Pharmacol Ther. 2018. PMID: 29444453 Review.
Cited by
-
MicroRNA and Hemostasis Profile of Carotid Atherosclerosis.Int J Mol Sci. 2022 Sep 19;23(18):10974. doi: 10.3390/ijms231810974. Int J Mol Sci. 2022. PMID: 36142883 Free PMC article.
-
Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications.Front Immunol. 2022 Aug 30;13:975367. doi: 10.3389/fimmu.2022.975367. eCollection 2022. Front Immunol. 2022. PMID: 36110847 Free PMC article. Review.
-
The Regulatory Role of MicroRNAs on Phagocytes: A Potential Therapeutic Target for Chronic Diseases.Front Immunol. 2022 May 11;13:901166. doi: 10.3389/fimmu.2022.901166. eCollection 2022. Front Immunol. 2022. PMID: 35634335 Free PMC article. Review.
-
The role of phosphatidylserine recognition receptors in multiple biological functions.Cell Mol Biol Lett. 2020 Mar 26;25:23. doi: 10.1186/s11658-020-00214-z. eCollection 2020. Cell Mol Biol Lett. 2020. PMID: 32226456 Free PMC article. Review.
-
Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease.Front Immunol. 2024 Nov 26;15:1485222. doi: 10.3389/fimmu.2024.1485222. eCollection 2024. Front Immunol. 2024. PMID: 39660125 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical